Comparison
Why is Medrx Co., Ltd. ?
- The company has reported losses. Due to this company has reported negative ROE
- Poor long term growth as Net Sales has grown by an annual rate of 1.43% and Operating profit at 5.26% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -1,187.04
- The company has reported losses. Due to this company has reported negative ROE
- NET SALES(Q) At JPY 6.04 MM has Fallen at -81.62%
- INVENTORY TURNOVER RATIO(HY) Lowest at 0.39 times
- RAW MATERIAL COST(Y) Grown by 96.79% (YoY)
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -9.72%, its profits have risen by 26.1%
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Medrx Co., Ltd. for you?
High Risk, Low Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Higher at JPY -561.03 MM
At JPY 6.04 MM has Fallen at -81.62%
Lowest at 0.39 times
Grown by 96.79% (YoY
Highest at -71.8 %
Lowest at JPY -294.21 MM
Lowest at -4,867 %
Lowest at JPY -309.3 MM
Lowest at JPY -312.67 MM
Lowest at JPY -5.25
Here's what is working for Medrx Co., Ltd.
Depreciation (JPY MM)
Depreciation (JPY MM)
Here's what is not working for Medrx Co., Ltd.
Net Sales (JPY MM)
Pre-Tax Profit (JPY MM)
Net Profit (JPY MM)
Inventory Turnover Ratio
Operating Profit (JPY MM)
Operating Profit to Sales
Pre-Tax Profit (JPY MM)
Net Profit (JPY MM)
EPS (JPY)
Debt-Equity Ratio
Raw Material Cost as a percentage of Sales






